Our speakers include: Mr Michael West, President & Chief Scientific Officer, Advanced Cell Technology Mr Hugh Ilyine, Vice President and Chief Operating Officer, Stem Cell Sciences Dr Thomas B Okarma, President and Chief Executive Officer, Geron Dr Ruth McKernan, Vice President, and Head of Discovery Biology, Pfizer Global Research and Development Mr Chris Mason, Regenerative Medicine Bioproessing Group, University College London Professor Ian Cotgreave, Director of Molecular Toxicoligy, Safety Assessment, AstraZeneca The distinguished speaking faculty have been drawn together from all corners of Europe, the Middle East and North America. No less than 20 of the worlds leading CxOs from global stem cell biotechs are represented at this event. Academia and Pharma are no lesser represented, with leading authorities in stem cell science and regenerative medicine providing their crucial insights on how to turn stem cell science into clinical practice. Click here for the full speaker list > “Well done with the conference!...I enjoyed it and found it very useful”   Aaron TT Chuang, Neurodegeneration Department, Neurology and Gastrointestinal Centre of Excellence for Drug Discovery, GlaxoSmithKline Also ... The Terrapinn difference We believeattending a conference should offer more than just the programme delivered in the same old format; it should be an insighful, fun and rewarding experience making your time at the event a memorable one. We introduce you to ‘Contact’- a system to enable you to set up meetings before the event. You can search the attendees then email them directly without ever seeing their e-mail address. The first contact is made and you can take it from there. More than just networking; important forms and congress tips can be downloaded and after the event you can even download the white papers and presentations from our world-class speakers. This is a revolutionary, exciting, quick and non pressurised way to meet fellow delegates in one 50 minute session. These brief meetings are the starting point for conversation and networking throughout the congress. This is where fruitful and long lasting relationships begin. The congress programme will include several panel sessions. These are chat show style sessions creating an interactive environment rather than a lecture. The panellists are chosen for their views and lively debate is encouraged. This is your chance to interact and put your questions to the panel.

Conference The first ever European Stem Cells & Regenerative Medicine Congress was a great success attracting 126 participants with eight sponsors and exhibitors. Of the 126 participants, 42% attended from biotech companies and 41% from research and academic institutes and 6% from the pharma industry. If this sounds like something you want to be part of then join us at the 2nd annual European Stem Cells and Regenerative Medicine Congress in London on 1st – 3rd May 2007 and reap the benefits - whatever your therapeutic specialty. The 2nd annual European Stem Cells and Regenerative Medicine Congress is scientific and commercially focused and is positioned as a 3-day event that will represent the pioneering work being conducted by 50 of the Worlds most respected research and commercial organisations. A sales and marketing solution that generates leads and new business Get cost effective marketing exposure and branding to your target audience, culminating in face-to-face meetings with your top prospects Position yourself as an industry leader Increase your brand recognition Create new partnerships and alliances Develop relationships through networking opportunities Showcase products and services to a targeted audience of industry experts and decision makers The European Stem Cells & Regenerative Medicine Congress 2006 can help you increase your profile in this ever growing area through a top class agenda and industry leading speakers. It facilitates the meetings and networking you need to increase profits. “The conference provided valuable insights into the spectrum of activity from academic research through development to end uses for stem cells in the regenerative medicine, drug discovery and toxicology applications, and the challenges remaining to bring stem cells into widespread use”   Hugh Ilyine, Vice President and Chief Operating Officer, Stem Cell Sciences   Make your voice heard! Now is the time to get involved in the 2007 event.   For speaking opportunities please contact: neil.darkes@terrapinn.com